Methods and compositions of treating a flaviviridae family viral infection
申请人:Einav Shirit
公开号:US20100015093A1
公开(公告)日:2010-01-21
Briefly described, embodiments of this disclosure include compounds, pharmaceutical compositions, methods of treating a host infected with a virus from the Flaviviridae family of viruses, methods of inhibiting HCV replication in a host, methods of inhibiting the binding of NS4B polypeptide to the 3′UTR of HCV negative strand RNA in a host, methods of treating liver fibrosis in a host, and the like.
Liquid crystal display and liquid crystalline medium
申请人:Manabe Atsutaka
公开号:US08945420B2
公开(公告)日:2015-02-03
The invention relates to an electro-optical liquid-crystal display which contains, as dielectric, a liquid-crystalline medium having negative dielectric anisotropy and includes a backlight which essentially only emits light having a wavelength of 400 nm or more or has, between the liquid-crystal layer and the backlight, a cut-off filter which essentially only allows light having a wavelength of 420 nm or more to pass through.
In particular, the liquid-crystalline medium comprises
a) a (first) dielectrically negative component (component A) which consists of one or more dielectrically negative compounds of the formula I
in which the parameters have the meanings indicated in claim 2, and a further (second) dielectrically negative component (component B). Very particular preference is given to the use of the liquid-crystalline media in an electro-optical display, particularly in an active-matrix display based on the VA, ECB, PSVA, FFS or IPS effect and very particularly in displays which use an LED backlight.